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1. Introduction 
Triple negative (TN) breast cancer is defined as cancer with negative expressions of 
hormone receptors and human epidermal growth factor receptor 2 (HER2). This subtype is 
characterized as a cancer with a high malignancy potential and a poor prognosis. Endocrine 
therapy and anti-HER2 therapy are ineffective in the treatment of TN breast cancer as they 
have less specific targets compared with other subtypes of breast cancer. At present, 
chemotherapy is the only option to treat this type of cancer. This subtype is found in 
approximately 15.5% of all breast cancer cases in Japan (Iwase et al., 2010). The percentage of 
other subtypes are as follows; Luminal A (hormone receptors positive and HER2 negative), 
69.0%; Luminal B (hormone receptors positive and HER2 positive), 7.3% and HER2-enriched 
(hormone receptor negative and HER2 positive), 8.2%.  Some reports described a subtype of 
DCIS that correlates to the progression to invasive carcinoma; comedo type DCIS progresses 
to invasive carcinoma, both more often and more rapidly than low-grade DCIS (Pinder SE & 
Ellis IO, 2003; Ketcham AS & Moffat FL, 1990). This may be a reason for the rarity of TN 
DCIS. The incidence of TN DCIS accounts for less than 5% of DCIS. If this is true, early 
detection of this particularly aggressive type of breast cancer is vital. (Moriya et al, 2010) 
There have been reports claiming that TN IDC occurs from ER negative, HER2 positive 
DCIS lesion and loses its HER2 expression when it progresses to an invasive cancer, which 
may indicate a precursor process is at work (Bradley BB et al., 2006; Livasy CA et al., 2007; 
Flora Z et al., 2007). To clarify these hypotheses, comparison between TN IDC and TN DCIS 
is also essential. There are no other reports that we were able to find that focus specifically 
on TN DCIS. We cannot predict the outcome of TN DCIS, if it is not diagnosed and treated, 
because this has not been researched nor documented (Page DL et al., 1995; Page DL et al., 
1982; Betsill WLJ et al., 1978). We reviewed another report on a series of cases in which DCIS 
was not completely excised. The findings from those reports indicate that a more frequent 
and rapid progression from DCIS to invasive cancer is related to the comedo subtype of 
DCIS, which is comparable to low-grade DCIS (Pinder SE & Ellis IO, 2003; Simpson JF, 
2009). We need to investigate the specific features of this subtype, and we need to determine 
the radiological and pathological features of TN breast cancer via retrospective evaluation in 
a large population, in order to make a more precise diagnosis. 
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2. Patients and methods 
TN breast cancer cases were studied by conducting chart reviews between January 2007 and 
January 2011 to assess mammogram (MMG), ultrasound (US), magnetic resonance imaging 
(MRI), methods of detection, and pathology findings. Routine diagnostic breast 
mammography, ultrasound, and MRI were performed before surgeries in our hospital. 
2.1 Mammography 
For each patient, mammograms with mediolateral oblique and craniocaudal view were 
carried out. In all cases, mammograms were retrospectively reviewed by two breast 
radiologists, and classified as focal asymmetric density (FAD), masses, calcifications, or 
architectural distortion, according to the Japanese mammography guidelines (The 
Committee of Mammography Guideline, 2010). Margins of masses were reviewed for being 
circumscribed, microlobulated, indistinct, and speculated. Mammography was performed 
by using Senographe 800T and Senographe DMR units from GE (films, MIN-R EV; screen, 
EV150) till August 2008. In August 2008, digital mammography with the Selenia from 
Hitachi was introduced. 
2.2 Ultrasound 
Each patient underwent whole-breast US which was performed and diagnosed by one of 
two radiologists, specialized in breast imaging. The ultrasound findings were classified as 
masses, low echoic area, distortions, and calcifications. Noted features included shapes 
(oval, lobulated, polygonal, or irregular), patterns of the internal echoes (hypoechoic, 
isoechoic, or hyperechoic), the posterior echoes (accentuating, no change, or attenuating), 
vascularity (avascular, spotty signals, hypovascular, hypervascular) and elasticity scores (1–
5; scores defined as previously reported (Itoh A et al., 2006)).  
For patients, ultrasound was performed by using 10 MHz linear-array transducers (LOGIQ 
7 system, GE) and 12 MHz linear-array transducers (HDI 5000, Philips) until September 
2007, and from October 2007, 12 MHz linear-array transducers (SSA 790A, Toshiba Medical 
Systems) and 14 MHz linear-array transducers (EUB 7500, Hitachi Medical) were used. All 
elasticity images were obtained by using EUB 7500. 
2.3 Magnetic resonance imaging 
The equipment used for MRI was a Signa Excite HD ver. 12 (1.5 Tesla) from GE with 4- or 8-
channel breast coil. The protocol was as follows: fat-suppressed T1WI, sagittal (pre-and 
post-enhancement) fast SPGR: TR/TE 6.5/1.5, FA 15°, FOV 16 cm, matrix 256 9 192, slice 
thickness 2 mm, scan time 2 min 10 s; fat-suppressed T2WI, sagittal FSE: TR/TE; 3,000/85, 
FOV 16 cm, matrix 256 9 224, slice thickness 5 mm, gap 1 mm, scan time 2 min 24 s; and 
delayed axial scan with VIBRANT: TR/TE 6.4/3.0, FOV 34 cm, matrix 350 9 350, slice 
thickness 1.2 mm, ASSET 2.0, scan time 2 min 40 s. 
2.4 Pathological findings 
All resected specimens were diagnosed by whole sectioning. Hematoxilin–eosin staining 
was performed in formalin-fixed, paraffin-embedded material for pathological diagnosis. 
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Immunohistochemistry of estrogen receptor (ER), progesterone receptor (PgR), and HER2 
were evaluated. The assessments of ER and PgR were done using Allred score, and the 
HER2 status was graded as 0, 1+, 2+, and 3+. HER2 score 3+ was defined as positive, and 2+ 
was checked by fluorescence in situ hybridization for its positivity. Five cases were 
eliminated, because the postoperative hormonal status turned out to be positive. In this 
cohort, 61 patients underwent neoadjuvant chemotherapy. 
3. Results 
Our cohort included 2,868 operations performed for primary breast cancer diagnosed in our 
institute between January 2007 and January 2011. Table 1 shows the characteristics of all 
triple-negative cases. Women with triple-negative invasive breast cancer were likely to have 
histologically higher-grade tumors compared to ductal carcinoma in situ. 
 
Age 56.3 (26-91) 
Ductal carcinoma in situ 
Size (cm) 
Nuclear grade 
1 
2 
3 
n=20 
2.9 (0.5-6.6) 
 
14 
3 
3 
Invasive cancer 
Size (cm) 
Nuclear grade 
1 
2 
3 
n=101 
2.6 (0.7-6.0) 
 
21 
26 
54 
Table 1. Characteristics of TN breast cancer patients (n=121). 
3.1 DCIS 
Our cohort included 657 DCIS patients, who were diagnosed and treated in our institute 
between January 2007 and January 2011. Among all 657 DCIS cases, 20 cases (3.0%) were 
ER-negative, PgR-negative, and HER2-negative. Ages in this group ranged from 40 to 73 
years old, with an average age of 55.8. In 12 cases, patients underwent partial resection, and 
in 8 cases, patients underwent total mastectomy. DCIS was confirmed in all patients by 
whole sectioning of the resected specimens. 
The radiology and pathology findings are shown in Table 2. Mammographic findings of TN 
DCIS were as follows: there were no abnormal findings in six cases, masses were revealed in 
two cases, FAD was detected in three cases, and architectural distortion was noted in five 
cases. However, calcifications, which have been considered as typical radiologcal findings in 
DCIS, were observed in only four cases (20.0%) out of our TN DCIS (Tables 2, 3). US 
findings were as follows: low echoic masses were noted in 7 cases, low echoic areas were 
noted in 14 cases, architectural distortion was noted in four cases. MRI findings revealed 
typical DCIS findings, including 7 masses and 12 non-mass-like enhancements (one patient 
did not undergo MRI). The average lesion size measured 2.9 cm in diameter (with a range of 
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0.5–8.5 cm). Fourteen cases were classified as nuclear grade (NG) 1, three cases were 
classified as NG2, and three cases were classified as NG3. Histological findings confirmed 
non-comedo type in 9 cases; mixed types, including some comedo components, were found 
in 8 cases; comedo type in 3 cases. In seven cases, apocrine metaplasia was observed, and in 
seven cases we noted a remarkable sclerosing adenosis in the background breast tissue areas 
of DCIS. 
 
case MMG US MRI NG Type of DCIS 
1 mass low echoic mass 
Non-mass like, segmental 
clumped enhancement 
1 mixed 
2 distortion 
low echoic area, 
distortion 
Non-mass like, ductal 
enhancement 
1 non-comedo, SA 
3 distortion low echoic mass 
Non-mass like, segmental 
homogenous enhancement 
1 non-comedo, SA 
4 no findings low echoic mass Mass 1 
non-comedo, 
apocrine 
metaplasia 
5 no findings low echoic area Mass 1 mixed 
6 no findings low echoic area 
Non-mass like, segmental 
homogenous enhancement 
3 mixed 
7 mass low echoic mass Not performed 1 comedo 
8 no findings low echoic area 
Non-mass like, segmental 
clumped enhancement 
2 
mixed, apocrine 
metaplasia 
9 FAD 
low echoic area, 
distortion 
Non-mass like, segmental 
clumped enhancement 
1 non-comedo, SA 
10 calcifications low echoic area Mass, foci 3 mixed 
11 distortion low echoic mass 
Non-mass like, segmental 
heterogenous enhancement 
1 
non-comedo, SA, 
apocrine 
metaplasia 
12 distortion 
low echoic area, 
distortion 
Mass 1 
non-comedo, SA, 
apocrine 
metaplasia 
13 calcifications low echoic area 
Non-mass like, segmental 
heterogenous enhancement 
2 mixed 
14 FAD low echoic area 
Non-mass like, segmental 
heterogenous enhancement 
1 mixed 
15 FAD low echoic mass Mass 2 mixed 
16 no findings low echoic area 
Non-mass like, segmental 
heterogenous enhancement 
1 
non-comedo, 
apocrine 
metaplasia 
17 calcifications low echoic area 
Non-mass like, segmental 
clumped enhancement 
3 comedo 
18 calcifications low echoic area Mass 1 comedo 
19 no findings low echoic area 
Non-mass like, segmental 
heterogenous enhancement 
1 
non-comedo, SA, 
apocrine 
metaplasia 
20 distortion low echoic mass Mass 1 
comedo, SA, 
apocrine 
metaplasia 
Table 2. Radiology and pathology findings of TN DCIS cases. 
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Findings Number (%) 
Calcifications 4 (20) 
Mass 2 (10) 
Focal asymmetric density 3 (15) 
Architectural destortion 5 (25) 
No abnormal findings 6 (30) 
Table 3. Mammogram findings of triple negative ductal carcinoma in situ. 
Representative cases are shown in Figs. 1 and 2. In the first case, the MMG revealed an 
architectural distortion in the right breast. Spot view revealed no abnormal calcifications. US 
revealed an irregularly shaped low echoic area with architectural distortion. The MRI 
revealed a non-mass like, segmental heterogenous enhancement. The pathological findings 
confirmed non-comedo DCIS, with sclerosing adenosis and apocrine metaplasia.  
 
 
 
    
 
Fig. 1.1. A first representative case of DCIS, mammography of the right breast. 
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Fig. 1.2. A first representative case of DCIS, mammography with spot view. 
 
Fig. 1.3. A first representative case of DCIS, Ultrasound. 
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Fig. 1.4. A first representative caseof DCIS, MRI.  
In the second case, MMG revealed a focal asymmetric density with architectural distortion 
in the right breast. US revealed an irregularly shaped low echoic mass. The MRI revealed a 
segmental enhancement with an architectural distortion. Pathological diagnosis confirmed 
DCIS with sclerosing adenosis.  
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Fig. 2.1. A second representative case of DCIS, mammography of the right breast. 
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Fig. 2.2. A second representative case of DCIS, Ultrasound; elastography (above) and collar 
Doppler view (below). 
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Fig. 2.3. A second representative case of DCIS, MRI. 
3.2 IDC 
Table 4 shows the radiological findings of TN invasive cancer in our study. On 
mammography, in almost all patients scattered fibrograndular (44/100, 44%) to 
heterogeneous (46/100, 46%) breast density was noted. Triple-negative breast cancers 
frequently presented with a mass (63/100, 63%) and were less associated with focal 
asymmetric density (13/100, 13%), calcifications (10/100, 10%), and distortion (5/100, 5%). 
Margins of masses were assessed. Masses with microlobulated margins were the most 
frequent (26/63, 41.3%), indistinct margins (19/63, 30.2%) and circumscribed margins 
(12/63, 19.0%) were commonly observed, but spiculated margins were rare (6/63, 9.5%). 
On ultrasound, cancers were less frequently observed as non-mass lesions (7/97, 7.2%), and 
were more likely to present as a mass (90/97, 92.8%); these were lobulated (42/90, 46.7%), 
irregular (17/90, 18.9%), or oval (24/90, 26.7%) in shape, and less likely to show attenuating 
posterior echoes (8/97, 8.2%). Of the 42 cases obtained via elasticity imaging, 35 (83.3%) 
lesions were scored as 4 or 5. 
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Mammography n=100 Ultrasound n=97  
 Density   Findings  
      Predominant fatty  6       Mass 90 
      Scattered fibrograndular 44       Non-mass like  7 
      Heterogeneously dense 46 
Architectural                
distortion 
 0 
      Dense  4       Calcifications  0 
    
 Findings   Shape of mass n=90  
     No abnormal findings 10       Oval 24 
     Focal asymmetric density 13       Lobulated 42 
     Mass 63       Irregular shape 17 
     Calcifications 10       Indistinct  7 
Architectural distortion  5   
   Posterior echoes  
 Border of mass n=63       Accentuating 43 
     Circumscribed 12        No change 46 
     Microlobulated 26       Attenuating  8 
     Indistinct 19   
     Spiculated  6  Vascularity  
        Avascular  7 
        Spotty signals 32 
        Hypovascular 38 
        Hypervascular 14 
    
   Elasticity score n=42 
  1~3  7  
  4, 5 35  
    
 
Table 4. Mammography and ultrasound findings for triple negative breast cancer patients 
Representative cases are shown in Figs. 3 and 4. On the mammogram of the first case, there 
were scattered fibroglandular elements in both breasts. There was a 2.3 cm oval high density 
mass with circumscribed margin in the left breast in the posterior depth of the superior 
region seen on the mediolateral oblique view which likely represents expansively growing 
tumor. On the ultrasound, there was an oval mass with circumscribed margin in the inner 
upper quadrant of the left breast. The tumor size was approximately 2.0 cm, slight spotty 
vasculature was seen at the edge of the tumor, and poor elasticity via elastography 
(elasticity score 4). MRI also showed an oval enhanced mass with circumscribed margin. 
The pathological findings confirmed invasive ductal carcinoma, nuclear grade 3, with fat 
invasion and lymphovascular invasion.  
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Fig. 3.1. A first representative case of IDC, mammography. 
 
Fig. 3.2. A first representative case of IDC, Ultrasound; B-mode and power Doppler. 
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Fig. 3.3. A first representative case of IDC, Ultrasound; elastography. 
 
Fig. 3.4. A first representative case of IDC, MRI. 
On the second case, mammogram revealed scattered fibroglandular elements in both 
breasts. There was an oval high density mass with microlobulated margins in the posterior 
depth of the superior region seen on the mediolateral oblique view of the right breast. The 
tumor sizes was 1.8 cm in diameter. On the ultrasound, there was a lobulated mass with 
circumscribed margin in the outer upper quadrant of the right breast. The mass showed 
mosaic pattern vasculature indicating hypervascularity of the tumor, and poor elasticity via 
elastography (elasticity score 4). MRI showed a circumscribed enhanced mass in the upper 
portion of the right breast. Pathological findings revealed invasive ductal cancer, nuclear 
grade 2. 
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Fig. 4.1. A second representative case of IDC, mammography. 
 
Fig. 4.2. A second representative case of IDC, Ultrasound; B-mode and power Doppler view. 
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Fig. 4.3. A second representative case of IDC, MRI. 
4. Discussion  
There are a few reports describing mammography and ultrasound findings of triple-
negative breast cancers (Ko ES et al., 2010; Wang Y et al., 2008; Yang WT et al., 2008). In 
those studies, comparisons were made between the mammography and ultrasound 
findings of hormone receptor negative, HER2-negative cancers with hormone receptor 
positive, HER2-negative cancers and hormone receptors negative, HER2-positive cancers. 
The radiological features of TN breast cancers included in our study were similar to the 
features described above. According to the Japanese data, hormone receptor positive 
breast cancer, such as luminal A or B, less likely to be found as a mass with pushing 
border compared to triple negative type cancers (Iwase H et al., 2010). Additionally, a few 
researchers have stated that triple-negative cancer is less frequently associated with 
calcifications, compared to the other subtypes. Collett et al. (Collett K et al., 2005) 
evaluated interval cancers diagnosed in a screening program between 1996 and 2001 and 
found that TN breast cancers were more likely than non-TN breast cancers to present in 
the interval between regular mammograms. The radiological features of TN breast cancer 
would give an answer to this. 
Wang et al. showed that triple–negative cancers are less likely to be associated with 
spiculated margins on mammography than estrogen receptor–negative human epidermal 
growth factor receptor–positive cancers are. In their series of 23 TN breast cancers, 9% were 
mammographically occult and only 23% had associated calcifications. (Wang Y et al., 2008). 
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Dent et al determined that patients with TN breast cancers had a much lower proportion of 
breast cancers first detected by mammography or ultrasound than patients with other breast 
cancers (19.6% versus 36.0%) (Dent R et al., 2007). 
Dogan et al reported that TN breast cancer features include; triple negative cancers were 
mammographically occult in 9% and sonographically occult in 7% of the patients (Dogan BE 
et al, 2010). When they could be visualized, the TN breast cancers had benign or 
indeterminate mammographic and sonographic findings, such as focal asymmetry (21%) 
and circumscribed round or oval masses (15.8%), despite their large size. Only three cases 
(6.8%) were identified as calcifications alone on mammography. Triple negative breast 
cancer is less likely to be detected in the routine screening using mammography alone. In 
contrast, all the cancers were visualized on MRI and showed characteristic findings 
associated with malignancy, as defined by the BI-RADS criteria. The most frequent MRI 
finding was a round or oval contrast-enhanced mass with irregular or spiculated margins 
and rim enhancements, (Schnall MD et al., 2006) and the characteristic shape is a common 
mammographic and ultrasound finding. Jinguji et al., who previously suggested an 
association of poor prognostic factors, such as nodal status, blood vessel invasion, and 
hormone receptor negativity, with rim enhancement on MRI, which are also some of the 
clinicopathological features of TN breast cancer. (Jinguji M et al., 2006) 
Uematsu et al. suggested frequent association of rim enhancements and smooth mass 
margins on their series of TN breast cancers. (Uematsu T et al., 2009) 
There are many reports describing the characteristic findings of MRI, although there are few 
describing those findings of mammogram or ultrasound. 
In our study, we determined the radiological characteristics, which were often observed as a 
mass (65%) on mammography. In the ultrasound findings, we noted that TN breast cancers 
were more likely to be seen as mass lesions (71%), with oval or lobulated shapes, and hypo-
echoic masses. Posterior echoes were less likely to attenuate, and vascularity was identified 
to some extent. From a previous report (Itoh A et al., 2006), the sensitivity, specificity, and 
accuracy of elastography were 83.3, 86.7, and 85.2%, respectively, with a cutoff score of 
between 3 and 4. Among the patients who were able to have elastography, TN breast cancer 
appeared as hard masses, with elasticity scores of 4 or 5. These findings represent TN tumor 
characteristics including high cellularity, less fibrous mass, and an elasticity score as high as 
ordinary invasive ductal carcinoma. 
Our study showed that only 20% (4/20) of TN DCIS were detected because of 
mammographic abnormal calcifications. To gain a better understanding of the character 
of this rare type of DCIS, we retrospectively reviewed the charts and reports of each 
case. 
Ordinarily, DCIS was first described a century ago by Dr. Joseph Bloodgood, but its natural 
history is poorly understood. In a large population-based surveillance, epidemiology, and 
end results series, Ernster et al. (Ernster VL et al., 2000) reported a 10-year mortality risk of 
DCIS of only 1.9%. Therefore, early detection is essential for improving the prognosis of 
breast cancer. The prognosis of TN invasive cancer is considered to be poor. If TN DCIS is a 
precursor of TN invasive carcinoma, detection of TN DCIS is attributed to appropriate 
treatment of the cases that may become TN invasive carcinoma.  
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DCIS was detected because of breast lumps or an abnormal discharge from the nipple. 
Through wider usage of MMG, and the development of radiological detection technologies 
capable of identifying breast abnormalities long before they become palpable, the frequency 
of DCIS detection has increased (Frykberg ER, 1997; Schnitt SJ et al., 1988; Dershaw DD, 
1989; Stomper PC, 1989; Ikeda DM & Anderson I, 1989). Historically, most cases of DCIS 
(72–80%) have been diagnosed by MMG. This is mainly because of abnormal calcifications, 
such as necrotic calcifications representing dead tumor cells or secretory calcifications in 
tumor nests. Only 10–12% of DCIS cases have been discovered because of masses without 
calcifications revealed by MMG. 
Abnormal calcifications are seen in approximately 62% (Ikeda DM & Andersson I, 1989) to 
72% of common DCIS cases (Kopans DB, 1998). The percentage in TN DCIS cases of 
abnormal calcifications is considerably lower than in common DCIS cases. 
In our cohort, the percentage of TN DCIS was only 3.0% of all DCIS. This percentage is 
much less than that of TN cancer rate in IDC cases. 
When we investigated the reason why TN DCIS is so rare, we were able to identify a few 
possibilities. TN DCIS may grow rapidly in a short time span, which makes it difficult to 
detect during its noninvasive term. This is one possibility that TN cancers were reported 
more likely to present in the interval between regular mammograms. TN invasive 
carcinoma is known to have rapid growth characteristics and has a poor prognosis. On the 
basis of pathology and molecular studies, some DCIS represents a precursor to invasive 
breast cancer; however, the proportion of untreated DCIS that will progress to invasive 
breast cancer is uncertain (Bradley BB et al., 2006; Livasy CA, 2007; Flora Z, 2007). Ko et al. 
suggest that triple-negative breast cancer may develope rapidly to an invasive stage with no 
major in situ components or to a precancerous stage; hence, such tumors lack calcifications 
on mammography (Ko ES et al., 2010). Moriya et al. reported the incidence of TN DCIS 
among DCIS as being less than 5% (Moriya T et al., 2010). They also think it is possible that 
TN DCIS transforms to invasive cancer in its early stage, not remaining preinvasive DCIS. 
However, the presence of precursor lesions of TN breast cancer has not been clarified, and 
its origin and development remain to be investigated. 
In our study, we identified a small number of patients (according to their mammograms) 
who were diagnosed as being without any abnormalities. If this were to happen in a normal 
screening process, such patients might slip through undiagnosed. We noted that ultrasound 
did indeed pick up all abnormalities. As a result, we can conclude that ultrasound used in 
combination with mammography is advantageous in detecting TN breast cancer. 
Among DCIS, subtypes of DCIS correlate to the progression to invasive carcinoma; comedo 
type DCIS progresses to invasive carcinoma, both more often and more rapidly than low-
grade DCIS (Pinder SE & Ellis IO, 2003; Ketcham AS & Moffat FL, 1990). From our findings, 
comedo components were frequently seen among lesions, and these comedo components 
are thought to be one reason for the rarity of TN DCIS. These results do not adequately 
explain the rarity of TN DCIS with its growth speed. The expression of ER, PgR, or HER2 is 
different between intraductal and invasive components within a patient in fewer cases, and 
its significance (whether it can be explained by dedifferentiation) has attracted a lot of 
interest recently. TN DCIS is thought to be a complex of several phenotypes. Not all TN 
DCIS cases progress rapidly to invasive cancer. 
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In lesions consistent with noninvasive and invasive components, the expression of HER2 
differs between these two components, positive in the noninvasive part, and negative in the 
invasive part. ER positivity between these two components is almost the same (50–75%), 
however, HER2 positivity in DCIS is much higher than in invasive cancer, 32–55 and 20–
25%, respectively. It is thought that a high proportion of DCIS lesions that progress to 
invasive lesions do lose overexpression of HER2 (Wiechmann L & Kuerer HM, 2008). 
Therefore, when hormone-negative and HER2-positive DCIS progresses to an invasive 
carcinoma, it becomes a TN invasive carcinoma, which might be another reason for the 
rarity of TN DCIS. 
Our findings suggest that TN DCIS cases are less likely to have calcifications in comparison 
with non-TN DCIS. TN DCIS are also detected mainly as masses or asymmetry. US and MRI 
findings of TN DCIS are almost the same as those of DCIS as seen in previous studies. From 
our data, almost all TN DCIS were observed as low echoic masses by US, which leads us to 
believe that US is a more important diagnostic tool than MMG in detecting TN DCIS. By 
using US more frequently, the detection rate of TN DCIS should be elevated. 
5. Conclusion  
We diagnosed TN DCIS in 3.0% of all DCIS cases. There were fewer incidences of 
mammographic abnormal calcifications with TN DCIS than with non-TN DCIS. 
Mammography and ultrasound imaging together revealed that the morphological features 
of TN breast cancer include a lobulated mass, with less attenuating posterior echoes, some 
vascularity, and low elasticity. 
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